FREE Stock Alerts By Email!
Hi ,
BISU, Their deal in the
CONGO could make
BISU a huge winner in your
portfolio, SOMETHING BIG IS COMING - TIME TO BUY
BISU is sitting @ .80
and is up 35% since our initial alert. The stock has been consolidating @
the .80 level. PSC think
BISU could come alive and make you some BIG MONEY
in the next five to ten times.
BISU`s GREENEX PRODUCT
SAVES LIVES. THIS PRODUCT MAKES
BISU A WORLD
LEADER IN THE FIGHT AGAINST MALARIA.
- As there is no vaccine available for protection
against malaria despite decades of research, there is a need for an
alternative method that offers a fairly reliable protection against malaria
and Greenex is the answer!
- Due to conflicts and wars, migrations, deteriorating
health systems, poverty, the parasites resistance to drugs and
insecticides, global warming and many other events make malaria extremely
difficult to control and sustain
- Greenex will be tested in the next three months in
Congo to finalize regulatory approval. This will be the last step prior to
final negotiation of a supply agreement in the next three to six months.
Health experts estimate that each child under five years of age in Congo
has 6 to 10 attacks of malaria per year. This is equivalent to as many as
100 million episodes, or even more, annually. Approximately 180,000
Congolese children under five die from the disease every year, and many
others are orphaned when malaria weakens and kills their parents.
MEMBERS NEED TO RE-READ THIS PR.
BISU IS ABOUT TO GO KABOOM.
Bio-Solutions Corp. Announces a Mission to Africa to Perform a Pilot
Trial of GreenEx(TM)
2009-11-17 08:34 ET - News Release
MONTREAL, QUEBEC -- (MARKET WIRE) -- 11/17/09
Bio-Solutions Corp. (OTCBB:
BISU), announces a mission to perform a pilot
trial for its main product GreenEx(TM) in a highly infested site within one
of the targeted countries.
In its growth framework and discussion with three African Countries,
Bio-Solutions Corp. accomplishes a second and important step, i.e. a first
pilot trial design to show on site efficiency of GreenEx(TM) in December,
2009. "We are proud to have the opportunity to show the effectiveness of
our product so quickly after its regulatory approval by the health
authorities of this West African country. Bio-Solutions Corp`s Team will
travel to the West African Country to evaluate the environmental condition
in order to develop the perfect spreading strategy to assure the success of
this experiment. This will be the final step prior to a commercial supply
agreement," declares Dr Chaumillon.
Bio-Solutions Corp commercial strategy and turnkey operation approach
seems to be the answer to the field problematic of the malaria infested
countries. "In less than 6 months we have registered our product with the
regulatory and conformity authorities. Now we are offered the possibility
to demonstrate the efficiency of the GreenEx(TM) product directly under
scrutiny of ministry of health experts." stressed Dr Chaumillon. Trial
design and experiment will be completed in the next 60 days before starting
the last phase; i.e. supply agreement negotiation.
For more information on Bio-Solutions Corp. and its products, please
visit the company`s website at www.bio-solutionscorp.com
Contacts:
Adrian McKenzie
Investor & Public Relations
561-654-5722
pbdcllc@gmail.com
Please remember to do your due diligence on
BISU.
We have not been compensated for this profile.
For more information on
BISU, please join us @ www.pennystockchaser.com.
This message was sent by: Pennystockchaser, PennyStockChaser
220 E. DELAWARE AVENUE, Newark, Delaware 19711
Email Marketing by iContact: http://freetrial.icontact.com
See Penny Stock Chaser's website for full disclaimer. Penny Stock Chaser may have received compensation for stock picks.
home
